The NHPig project has been featured in a recent Bloomberg article highlighting the growing role of minipigs in European drug development.
The article discusses the European Union’s efforts to strengthen resilience in preclinical research and highlights the increasing use of minipigs as an alternative to non-human primates. It refers to initiatives such as NHPig that contribute to advancing the scientific knowledge needed to support this shift.
Read the full article:
https://www.bloomberg.com/news/articles/2026-02-27/europe-turns-to-minipigs-to-replace-monkeys-in-drug-testing
(Please note that access may require a subscription.)
